Analyst firms · Vertical Research · CE

Vertical Research CE price target and rating history

Celanese Corporation (CE) · Industrials

Vertical Research rates Celanese Corporation (CE) Buy with a $60 price target, as of its latest action on Mar 9, 2026. It has published 5 rating actions on CE since July 2021, including 3 upgrades and 2 downgrades. Across 6 firms with a CE price target in the last 12 months, the median target is $58.50. Vertical Research's $60 is 3% above that.

Current rating
Buy
Price target
$60
Median target, all firms
$58.50
Actions on CE
5

Vertical Research price target on CE

$196$128$6020222023202420252026
Vertical Research price target on CE, each point a stated target, July 2021 to March 2026.

Every Vertical Research rating on CE

How other firms rate CE

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BarclaysEqual Weight$49Oct 13, 2026
KeyBanc Capital MarketsOverweight$57Sep 11, 2026
Wells FargoOverweight$70Mar 13, 2026
Vertical ResearchBuy$60Mar 9, 2026
Tudor, Pickering, Holt & Co.BuyMar 9, 2026
JefferiesBuy$86Feb 5, 2026
Morgan StanleyEqual-Weight$50Jan 20, 2026

Questions about Vertical Research and CE

What is Vertical Research's price target for CE?
Vertical Research's latest stated price target for Celanese Corporation (CE) is $60, from its action on Mar 9, 2026.
What is Vertical Research's rating on CE?
Vertical Research rates CE Buy, a bullish rating, as of Mar 9, 2026.
When did Vertical Research last change its view on CE?
On Mar 9, 2026, Vertical Research upgrades to Buy from Hold, price target $60.
How does Vertical Research's CE target compare with other analysts?
Across 6 firms with a CE price target in the last 12 months, the median target is $58.50. Vertical Research's $60 is 3% above that.

More CE rating histories

All Vertical Research ratingsCE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.